Drainage or Pericardiocentesis (DROP) Alone for Recurrent Non-malignant Pericardial Effusions Requiring Intervention
- Conditions
- Pericardial Effusion
- Registration Number
- NCT01665495
- Lead Sponsor
- Maria Vittoria Hospital
- Brief Summary
The DROP study is a prospective, multi center, randomized, open-label trial to test the efficacy and safety of extended catheter pericardial drainage in patients with non-malignant pericardial effusions.
- Detailed Description
The trial will compared the efficacy and safety of pericardiocentesis alone compared with extended pericardial catheter drainage for the prevention of recurrent effusions in patients with non-malignant pericardial effusions requiring intervention.
Recruitment & Eligibility
- Status
- UNKNOWN
- Sex
- All
- Target Recruitment
- 122
- adult patients
- pericardial effusion requiring pericardiocentesis
- non-malignant etiology
- known neoplastic etiology
- known bacterial etiology
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Primary Outcome Measures
Name Time Method Recurrent pericardial effusion 12 months Need for cardiac surgery 12 months Need for repeated pericardiocentesis 12 months
- Secondary Outcome Measures
Name Time Method Hospital stay 12 months Disease-related hospitalization 12 months Overall mortality 12 months
Trial Locations
- Locations (7)
Ospedali Riuniti
🇮🇹Bergamo, Italy
Ospedale Regionale San Maurizio
🇮🇹Bolzano, Italy
Ospedale Niguarda
🇮🇹Milan, Italy
Ospedale degli Infermi
🇮🇹Rivoli, Italy
Cardiology Department, Maria Vittoria Hospital
🇮🇹Torino, Italy
Cardiology Department, Ospedale San Giovanni Bosco
🇮🇹Torino, Italy
Ospedale Mauriziano
🇮🇹Torino, Italy
Ospedali Riuniti🇮🇹Bergamo, ItalyAntonio Brucato, MDPrincipal Investigator